US$ 24.64
the benefits of glp-1 drugs beyond obesity are changing more than number on the scale. From diabetes and to heart, kidney, and metabolic health — this story is getting bigger fast. ❤️ Swipe to learn Next wave of obesity drugs
Description
Wan X, Wang W, Liu J, Tong T

Consort flow diagram

There was a dose-response relationship between liraglutide and increased nitric oxide generation in
Recent phase 2 and phase 3 clinical trials have established the therapeutic value of various GLP-1 RAs in improving liver histology and metabolic parameters in patients with MASH

30, Sept